Radiographic and Clinical Outcomes After Short-Stem Reverse Shoulder Arthroplasty (STEP2yrs)

June 10, 2026 updated by: Krankenhaus Barmherzige Schwestern Linz

Humeral-Sided Radiographic Changes and Clinical Outcome After Reverse Total Shoulder Arthroplasty With Short Stem - Minimum 2-Year Follow-Up

Reverse total shoulder arthroplasty (RTSA) has become increasingly common in recent years due to expanding indications and improved surgical techniques. Short-stem humeral implants have gained attention because they preserve bone stock, allow metaphyseal fixation, and facilitate potential revision procedures.

The aim of this study is to evaluate radiographic and clinical outcomes following reverse shoulder arthroplasty with a short humeral stem after a minimum follow-up of two years. Patients who underwent RTSA at the Department of Orthopedics at Ordensklinikum Linz will be invited for clinical and radiographic follow-up.

Clinical outcomes will be assessed using established shoulder scores including the Constant Score, the American Shoulder and Elbow Surgeons (ASES) score, and the Simple Shoulder Test (SST). Radiographic evaluation will focus on humeral-sided changes such as stress shielding, radiolucent lines, osteolysis, and fractures. Patient satisfaction will additionally be assessed using visual analogue scales and patient-reported outcome measures.

Demographic variables, comorbidities, and implant-related characteristics will be collected to allow descriptive evaluation of factors potentially associated with clinical and radiographic outcomes.

Study Overview

Detailed Description

Retrospective with prospective follow-up

Study Type

Observational

Enrollment (Estimated)

50

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Linz, Austria, 3340
        • Ordensklinikum Linz - Barmherzige Schwester

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

The study population consists of adult patients who underwent reverse total shoulder arthroplasty with a short humeral stem at the Department of Orthopedics, Ordensklinikum Linz, Austria. All eligible patients who received this procedure at least two years prior to enrollment will be invited for a clinical and radiographic follow-up examination.

Participants are identified through institutional medical records and include both male and female patients. Only patients who provide written informed consent will be included in the study.

Description

Inclusion Criteria:

  • Reverse shoulder arthroplasty with short humeral stem
  • Surgery performed at Ordensklinikum Linz
  • Minimum postoperative follow-up of 2 years
  • Written informed consent

Exclusion Criteria:

  • Perioperative complications not related to the surgical procedure
  • Lack of consent for study participation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Radiographic Changes of the Humeral Component
Time Frame: ≥2 years postoperatively

Assessment of humeral-sided radiographic changes including:

Stress shielding Radiolucent lines Osteolysis Periprosthetic fractures

Measured using standardized radiographs at follow-up.

≥2 years postoperatively

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Constant-Murley Score (Constant Score)
Time Frame: up to 3 years postoperatively
The Constant Score is a comprehensive shoulder function assessment. The total score ranges from 0 to 100 points. Higher scores indicate better shoulder performance and function; lower scores indicate greater functional impairment and symptoms.
up to 3 years postoperatively
American Shoulder and Elbow Surgeons Score (ASES)
Time Frame: up to 3 years postoperatively
The American Shoulder and Elbow Surgeons Score is used to assess shoulder pain and function. The total score ranges from 0 to 100 points. Higher scores indicate better shoulder function, less pain, and fewer activity limitations; lower scores indicate greater pain, impaired shoulder function, and increased disability.
up to 3 years postoperatively
Simple Shoulder Test Score (SST)
Time Frame: up to 3 Years Postoperatively
Shoulder function will be assessed using the Simple Shoulder Test. The total score ranges from 0 to 12 points. Higher scores indicate better shoulder function.
up to 3 Years Postoperatively
Return to Sport Rate (RTS)
Time Frame: up to 3 years postoperatively
Return to sport will be assessed as the proportion or percentage of patients who returned to sport participation after surgery. Higher percentages indicate a better outcome, reflecting a greater rate of successful return to sport.
up to 3 years postoperatively

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2026

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

December 31, 2026

Study Registration Dates

First Submitted

June 1, 2026

First Submitted That Met QC Criteria

June 10, 2026

First Posted (Actual)

June 16, 2026

Study Record Updates

Last Update Posted (Actual)

June 16, 2026

Last Update Submitted That Met QC Criteria

June 10, 2026

Last Verified

June 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • 1035/2026

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Shoulder Arthroplasty

Subscribe